Nutrite Healthcare Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 30-07-2024
- Paid Up Capital ₹ 9.60 Cr
as on 30-07-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -96.40%
(FY 2023)
- Profit 18.19%
(FY 2023)
- Ebitda 92.03%
(FY 2023)
- Net Worth -16.04%
(FY 2023)
- Total Assets -40.60%
(FY 2023)
About Nutrite Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vikram Tannan, Vivek Tannan, Ashish Jajodia, and One other member serve as directors at the Company.
- CIN/LLPIN
U15115MH2017PTC297891
- Company No.
297891
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Nutrite Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram Tannan  | Director | 26-Jul-2017 | Current |
| Vivek Tannan | Director | 26-Jul-2017 | Current |
| Ashish Jajodia | Director | 26-Jul-2017 | Current |
| Saif Mehkri | Director | 26-Jul-2017 | Current |
Financial Performance and Corporate Structure Insights of Nutrite Healthcare.
Nutrite Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 96.4% decrease. The company also saw a substantial improvement in profitability, with a 18.19% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nutrite Healthcare?
In 2023, Nutrite Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Universal Medicare Private LimitedActive 53 years 4 monthsVikram Tannan and Vivek Tannan are mutual person
Universal Nutriscience Private LimitedActive 3 years 6 monthsVikram Tannan and Vivek Tannan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nutrite Healthcare?
Nutrite Healthcare has a workforce of 2 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nutrite Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutrite Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
